title: Improving access for anti-tumour necrosis factor-a therapy in inflammatory bowel disease.
authors.forename: Nicholas A
authors.initials: NA
authors.lastname: Biehl
authors.forename: Janina
authors.initials: J
authors.lastname: Pawlik
authors.forename: Geoffrey M
authors.initials: GM
authors.lastname: Forbes
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001315:Australia; D003424:Crohn Disease / Q000188:drug therapy*; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D000069285:Infliximab; D007356:Insurance, Pharmaceutical Services; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab